Expertise in
15
conditions

Moshe P. Phillip

14 Kaplan Street, 
Petah Tiqwa, M, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
15
conditions
14 Kaplan Street, 
Petah Tiqwa, M, IL 

Overview

Moshe Phillip practices practicing medicine in Petah Tiqwa, Israel.

Mr. Phillip is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Precocious Puberty, Idiopathic Short Stature (ISS), and Low Blood Sugar.

He is actively involved in clinical research, co-authoring 263 peer reviewed articles and participating in 11 clinical trials.

Gender

Male

Locations

14 Kaplan Street, Petah Tiqwa, M 49202, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Screening for Islet Autoantibodies in the Israeli Paediatric General Population for Detection of Pre-symptomatic Type-1 Diabetes Mellitus
Screening for Islet Autoantibodies in the Israeli Paediatric General Population for Detection of Pre-symptomatic Type-1 Diabetes Mellitus
Enrollment Status: Recruiting
Publish Date: October 17, 2024
Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls
Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Evaluation of the Correlation Between Psychological Intervention, Including Providing Knowledge and Tools for Problems Solving, and the Anxiety Level of Female Patients Arriving to ACTH LRH Test - Pilot Study
Evaluation of the Correlation Between Psychological Intervention, Including Providing Knowledge and Tools for Problems Solving, and the Anxiety Level of Female Patients Arriving to ACTH LRH Test - Pilot Study
Enrollment Status: Terminated
Publish Date: April 12, 2024
Intervention Type: Behavioral
Study Phase: Not Applicable
Patients Perceptions of Using the Libre System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat Trial
Patients Perceptions of Using the Libre System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat Trial
Enrollment Status: Completed
Publish Date: August 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
Fluids Administration During Combined Clonidine-Arginine Growth Hormone Stimulation Test- Randomized, 2 Arms, Controlled Study
Fluids Administration During Combined Clonidine-Arginine Growth Hormone Stimulation Test- Randomized, 2 Arms, Controlled Study
Enrollment Status: Withdrawn
Publish Date: February 22, 2022
Intervention Type: Procedure
Study Phase: Not Applicable
An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Glycemic Control Using Hybrid-closed Loop vs. Advanced Hybrid Closed-loop in Young Subjects With Type 1 Diabetes
An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Glycemic Control Using Hybrid-closed Loop vs. Advanced Hybrid Closed-loop in Young Subjects With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: February 22, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog With an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: January 24, 2022
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro
Study Phase: Phase 3
An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes at Home
An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes at Home
Enrollment Status: Withdrawn
Publish Date: December 30, 2019
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- Open Label, Parallel , Randomized, Controlled Multicenter Study-The Advice4U Pro Study
Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- Open Label, Parallel , Randomized, Controlled Multicenter Study-The Advice4U Pro Study
Enrollment Status: Completed
Publish Date: December 27, 2019
Intervention Type: Device, Other
Study Phase: Not Applicable
Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2
Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2
Enrollment Status: Completed
Publish Date: December 27, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

263 Total Publications

Comparative Analysis of Capillary HbA1c and CGM-Derived GMI Estimates: A Real-World Data from a Single Center.
Comparative Analysis of Capillary HbA1c and CGM-Derived GMI Estimates: A Real-World Data from a Single Center.
Journal: Diabetes technology & therapeutics
Published: June 19, 2026

Frequently Asked Questions about Moshe P. Phillip

Is Moshe P. Phillip a top-rated expert for Type 1 Diabetes (T1D)?

MediFind is an objective health platform that identifies experts based on real-world data. Moshe P. Phillip is classified as an Elite expert for Type 1 Diabetes (T1D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Moshe P. Phillip participate in research or clinical trials?

Yes. Moshe P. Phillip has published 263 articles and abstracts on conditions like Type 1 Diabetes (T1D). You can view a list of Moshe P. Phillip's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Phillip's expertise for a condition
ConditionClose
View All 30 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile